Search   
MSDS  : 2,6-Epoxy-2H-naphthaceno(1,2-b)oxocin-9,16-dione, 4-(dimethylamino)-3,4,5,6,11,12,13,14- octahydro-3,5,8,10,13-pentahydroxy-11-methoxy-6,13-di methyl-, (2-alpha,3-beta,4-alpha,5- beta,6-alpha,11-alpha,13-alpha)-(+)-
CAS  : 71628-96-1
SYNONYMS  : * 7-Con-O-methylnogaril * 7-Con-O-methylnogarol * Menogaril * 7(R)-O-Methylnorgarol * NSC-269,148 * 7-OMEN * TUT-7 * U-52047
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : KD1146400
CHEMICAL NAME : 2,6-Epoxy-2H-naphthaceno(1,2-b)oxocin-9,16-dione,
4-(dimethylamino)-3,4,5,6,11,12,13,14-
octahydro-3,5,8,10,13-pentahydroxy-11-methoxy-6,13-di
methyl-, (2-alpha,3-beta,4-alpha,5-
beta,6-alpha,11-alpha,13-alpha)-(+)-
CAS REGISTRY NUMBER : 71628-96-1
OTHER CAS REGISTRY NOS. : 69256-91-3
LAST UPDATED : 199801
DATA ITEMS CITED : 30
MOLECULAR FORMULA : C28-H31-N-O10
MOLECULAR WEIGHT : 541.60
WISWESSER LINE NOTATION : T I6 G6 E6 D666 A AO CO FV QVT&&&TTJ KQ K1 MO1 OQ SQ
V1 WQ A&N1&1 B&Q
COMPOUND DESCRIPTOR : Drug
Mutagen
Reproductive Effector
Human
SYNONYMS/TRADE NAMES :
* 7-Con-O-methylnogaril
* 7-Con-O-methylnogarol
* Menogaril
* 7(R)-O-Methylnorgarol
* NSC-269,148
* 7-OMEN
* TUT-7
* U-52047

*** HEALTH HAZARD DATA ***

** ACUTE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Human
DOSE/DURATION : 5189 ug/kg
TOXIC EFFECTS :
Blood - granulocytopenia
Skin and Appendages - hair
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
46,2562,1986

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 1788 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Liver - other changes
Gastrointestinal - other changes
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 28,125,1997

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 802 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Liver - other changes
Nutritional and Gross Metabolic - weight loss or decreased weight gain
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 28,125,1997

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >1500 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Skin and Appendages - dermatitis, other (after systemic exposure)
Nutritional and Gross Metabolic - weight loss or decreased weight gain
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 28,125,1997

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 77400 ug/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Skin and Appendages - hair
Nutritional and Gross Metabolic - weight loss or decreased weight gain
REFERENCE :
NTIS** National Technical Information Service. (Springfield, VA 22161)
Formerly U.S. Clearinghouse for Scientific & Technical Information.
Volume(issue)/page/year: PB84-148410

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 607 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Behavioral - tremor
Behavioral - convulsions or effect on seizure threshold
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 28,125,1997

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 83500 ug/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Skin and Appendages - hair
Nutritional and Gross Metabolic - weight loss or decreased weight gain
REFERENCE :
NTIS** National Technical Information Service. (Springfield, VA 22161)
Formerly U.S. Clearinghouse for Scientific & Technical Information.
Volume(issue)/page/year: PB84-148410

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >1500 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Skin and Appendages - dermatitis, other (after systemic exposure)
Nutritional and Gross Metabolic - weight loss or decreased weight gain
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 28,125,1997

TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : 16 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Gastrointestinal - hypermotility, diarrhea
Gastrointestinal - nausea or vomiting
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 28,125,1997

TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : 10 mg/kg
TOXIC EFFECTS :
Behavioral - food intake (animal)
Gastrointestinal - hypermotility, diarrhea
Gastrointestinal - nausea or vomiting
REFERENCE :
NTIS** National Technical Information Service. (Springfield, VA 22161)
Formerly U.S. Clearinghouse for Scientific & Technical Information.
Volume(issue)/page/year: PB84-148410

** OTHER MULTIPLE DOSE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 350 mg/kg/5W-I
TOXIC EFFECTS :
Endocrine - changes in spleen weight
Blood - changes in erythrocyte (RBC) count
Blood - changes in leukocyte (WBC) count
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 28,136,1997

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 910 mg/kg/13W-I
TOXIC EFFECTS :
Endocrine - changes in thymus weight
Blood - normocytic anemia
Blood - changes in leukocyte (WBC) count
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 28,136,1997

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : 35 mg/kg/5W-I
TOXIC EFFECTS :
Kidney, Ureter, Bladder - proteinuria
Blood - changes in leukocyte (WBC) count
Related to Chronic Data - death
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 28,179,1997

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : 27300 ug/kg/13W-I
TOXIC EFFECTS :
Blood - changes in bone marrow (not otherwise specified)
Blood - changes in spleen
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 28,179,1997

** REPRODUCTIVE DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 11 mg/kg
SEX/DURATION : female 7-17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - extra-embryonic structures
(e.g., placenta, umbilical cord)
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
e.g., stunted fetus)
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight
gain)
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 27,776,1996

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 480 mg/kg
SEX/DURATION : male 9 week(s) pre-mating
female 2 week(s) pre-mating - 19 day(s) after
conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or
resorbed implants per total number of implants)
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
e.g., stunted fetus)
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 27,756,1996

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 595 mg/kg
SEX/DURATION : male 9 week(s) pre-mating
female 2 week(s) pre-mating - 21 day(s) post-birth
TOXIC EFFECTS :
Reproductive - Effects on Newborn - live birth index (measured after birth)
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 27,756,1996

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 55 mg/kg
SEX/DURATION : female 7-17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - physical
Reproductive - Effects on Newborn - other postnatal measures or effects
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 27,776,1996

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rabbit
DOSE : 156 mg/kg
SEX/DURATION : female 6-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Maternal Effects - other effects
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 27,805,1996

** MUTATION DATA **

TYPE OF TEST : Micronucleus test
ROUTE OF EXPOSURE : Parenteral
TEST SYSTEM : Rodent - rat
DOSE/DURATION : 1560 ug/kg/2D (Intermittent)
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
43,5293,1983

TYPE OF TEST : Micronucleus test
ROUTE OF EXPOSURE : Intraperitoneal
TEST SYSTEM : Rodent - mouse
DOSE/DURATION : 4 mg/kg
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE
Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 223,129,1989

TYPE OF TEST : DNA inhibition
TEST SYSTEM : Rodent - mouse Leukocyte
DOSE/DURATION : 4600 nmol/L
REFERENCE :
JANTAJ Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8
Kamiosaki, Shinagawa-ku, Tokyo, 141, Japan) V.2-5, 1948-52; V.21- 1968-
Volume(issue)/page/year: 34,1596,1981

TYPE OF TEST : Mutation test systems - not otherwise specified
TEST SYSTEM : Rodent - mouse Leukocyte
DOSE/DURATION : 8100 nmol/L
REFERENCE :
JANTAJ Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8
Kamiosaki, Shinagawa-ku, Tokyo, 141, Japan) V.2-5, 1948-52; V.21- 1968-
Volume(issue)/page/year: 34,1596,1981

TYPE OF TEST : DNA inhibition
TEST SYSTEM : Rodent - hamster Ovary
DOSE/DURATION : 200 ug/L
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
41,4981,1981

TYPE OF TEST : Cytogenetic analysis
TEST SYSTEM : Rodent - hamster Lung
DOSE/DURATION : 300 ug/L/2H
REFERENCE :
ENMUDM Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For
publisher information, see EMMUEG. Volume(issue)/page/year: 2,249,1980

TYPE OF TEST : Sister chromatid exchange
TEST SYSTEM : Rodent - hamster Lung
DOSE/DURATION : 300 ug/L/2H
REFERENCE :
ENMUDM Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For
publisher information, see EMMUEG. Volume(issue)/page/year: 2,249,1980

TYPE OF TEST : Mutation in mammalian somatic cells
TEST SYSTEM : Rodent - hamster Lung
DOSE/DURATION : 100 ug/L
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
43,5293,1983

TYPE OF TEST : DNA damage
TEST SYSTEM : Mammal - species unspecified Lymphocyte
DOSE/DURATION : 12 umol/L
REFERENCE :
CBINA8 Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland
Ltd., POB 85, Limerick, Ireland) V.1- 1969- Volume(issue)/page/year:
36,1,1981

TYPE OF TEST : DNA inhibition
TEST SYSTEM : Mammal - species unspecified Lymphocyte
DOSE/DURATION : 12 umol/L
REFERENCE :
CBINA8 Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland
Ltd., POB 85, Limerick, Ireland) V.1- 1969- Volume(issue)/page/year:
36,1,1981

TYPE OF TEST : Mutation test systems - not otherwise specified
TEST SYSTEM : Mammal - species unspecified Lymphocyte
DOSE/DURATION : 12 umol/L
REFERENCE :
CBINA8 Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland
Ltd., POB 85, Limerick, Ireland) V.1- 1969- Volume(issue)/page/year:
36,1,1981

*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
9,13-Epoxy-1H,9H-diindolo(1,2,3-gh3',2',1'-lm)pyrrolo(3,4-j)(1,7)benzodia zonin-1-one,2,3,10,11,12,13-hexahydro-3-hydroxy-10-methoxy-9-methyl-11-(methylamino)-, (3-alpha,9-beta,10-alpha,11-alpha,13-beta)-(+)- 112953-11-4
5,9a-Epoxy-3H,9aH-furo(3,4-f)pyrano(4,3,2-de)(1)benzopyran-1,8(7H,10H)-dio ne, hexahydro-5-(3-furanyl)-7,9b,11a-trimethyl-,(5R-(3aS*,5-alpha,6a-beta,7-alpha,9a-alpha,9b-beta,11a- alpha))- 94978-16-2
3a,7-Epoxy-3aH-furo(3,2-b)oxocin-3-carboxylic acid,octahydro-5-(6-(2,5-dihydro-4-hydroxy-1-methyl-2-oxo-1H-pyrrol-3-yl)-1,3-dimethyl-6-oxo-2,4-hexadienyl)-2,6,9a-tri methyl-8-oxo-, methyl ester,sodium salt,(2R-(2-alpha,3-alpha,3a-alpha,5-alpha(1R*,2E,4E),6-beta,7- alpha,9a-beta))- 69831-38-5
3a,7-Epoxy-3aH-furo(3,2-b)oxocin-3-carboxylic acid,octahydro-5-(6-(2,5-dihydro-4-hydroxy-2-oxo-1H-pyrrol-3-yl)-1,3-dimethyl-6-oxo-2,4-hexadienyl)-2,6,9a-trimethyl-8- oxo-, methyl ester, sodiumsalt,(2R-(2-alpha,3-alpha,3a-alpha,5-alpha(1R*,2E,4E),6-beta,7-alpha,9a-beta))- 6-beta,7-alpha,9a-beta))- 69831-39-6
Disulfide,bis(2-((4-(2,6-xylyloxy)butyl)amino)ethyl)-,dihydrochloride 38920-79-5
Epoxy hardener zzl-0814 38920-79-5
Epoxy hardener zzl-0816 38920-79-5
Epoxy hardener zzl-0822 69136-21-6
Epoxy hardener zzl-0854 69136-21-6
Epoxy hardener zzla-0334 42498-58-8
4a,14a-Epoxy-4,14-(3)hexene(1,5)diynonaphtho(2,3-c)phenanthridine-2-carbox ylic acid,1,4,7,12,13,14-hexahydro-7,12-dioxo-3-methoxy-1-methyl-6,8,11-trihydroxy-, (1S-(1R*,4S*,4aS*,14R*,14aR*))- 124412-57-3
6,9-Epoxy-5H,9H-imidazo(2,1-c)(1,4)oxazepine,6,7-dihydro-9-phenyl- 76099-37-1
4,7-Epoxy-1H-indene-3a,7a-dicarboxylic acid,hexahydro-, (3a-alpha,4-alpha,7-alpha,7a-alpha)- 127311-85-7
4,7-Epoxy-1H-indene-1,3(2H)-dione, hexahydro-,(3a-alpha,4-beta,7-beta,7a-alpha)- 109428-60-6
4,7-Epoxyisobenzofuran-5-acetonitrile,octahydro-1,3-dioxo-, (3a-alpha,4-beta,5-alpha,7-beta,7a-alpha)- 127311-93-7
Disulfide, butyl 1,2,2-trichloroethyl 4560-93-4
4,7-Epoxyisobenzofuran-5-carboxylic acid,octahydro-1,3-dioxo-, (3a-alpha,4-beta,5-alpha,7-beta,7a-alpha)- 127311-90-4
4,7-Epoxyisobenzofuran-5-carboxylic acid,octahydro-1,3-dioxo-, ethyl ester, (3a-alpha,4-beta,5-alpha,7-beta,7a-alpha)- 127311-88-0
4,7-Epoxyisobenzofuran-1,3-dione,hexahydro-3a-methyl-,(3a-alpha,4-beta,7-beta,7a-alpha)- 127380-62-5
4,7-Epoxyisobenzofuran-1,3-dione,3a,4,7,7a-tetrahydro-,(3a-alpha,4-beta,7-beta,7a-alpha)- 6118-51-0
4,7-Epoxyisobenzofuran-1(3H)-one, hexahydro-,(3a-alpha,4-beta,7-beta,7a-alpha)- 51155-03-4
4,7-Epoxyisoindole-2-carboxylic acid, octahydro-,isopropyl ester 73986-88-6
4,7-Epoxy-1H-isoindole-1,3(2H)-dione,hexahydro-2-ethyl-, (3aR-(3a-alpha,4-beta,7-beta,7a-alpha))- 70223-91-5
4,7-Epoxy-1H-isoindole-1,3(2H)-dione,hexahydro-2-hydroxy-3a,7a-dimethyl-,(3a-alpha,4-beta, 7-beta,7a-alpha)- 76057-97-1
4,7-Epoxyisoindoline,hexahydro-2-(dimethylthiocarbamoyl)- 73986-89-7
4,7-Epoxyisoindoline,hexahydro-4-methyl-2-(3-phenothiazin-10-ylpropyl)-,hydrochloride 6593-05-1
Disulfide, p-chlorophenyl trichloromethyl 52739-88-5
4,7-Epoxyisoindolinium,hexahydro-2,4-dimethyl-2-(2-trimethylammonioethyl)-,dichloride 52739-88-5
4,7-Epoxyisoindolinium,hexahydro-2,4-dimethyl-2-(trimethylammonioethyl)-,dichloride, theophyllinate 52739-88-5
5,10-(Epoxymethano)-5H-dibenzo(a,d)cyclohepten-12-one, 10,11-dihydro- 26899-93-4
1H,3H-4,7-Epoxy-3a,7a-methanoisobenzofuran-1,3-dione,tetrahydro-, (3a-alpha,4-beta,7- beta,7a-alpha)- 109282-29-3
1,4-(Epoxymethanol)-1H,3H-(1,4)oxazepino(4,3-a)benzimidazole, 4,5-dihydro-1-phenyl- 76099-35-9
2H-3,11c-beta-(Epoxymethano)phenanthro(10,1-bc)pyran-3-alpha(3a-beta-H)-ca rboxylic acid,1,4,5,6a-beta,7,7a-alpha,10,11,11a,11b-alpha-decahydro-8,11a-beta-dimethyl -5,10-dioxo-1-beta,2-alpha,4-beta,9-tetrahydroxy-, methyl ester,4-(3-methylcrotonate) 14907-98-3
5H-3,11c-beta-(Epoxymethano)phenanthro(10,1-bc)pyran-5,10(6a-beta-H)-dione, 1,2,3,3a,4,7,7a-alpha,11,11a,11b-alpha-decahydro-1-beta,2-alpha,3a-beta,4-beta,11-beta- pentahydroxy-3-alpha,8,11a-beta-trimethyl-, (-)- 21499-66-1
2H-1,11c-(Epoxymethano)phenanthro(10,1-bc)pyran-5,10(3H,6ah)-dione, 1,3a,4,7,7a,11,11a,11b-octahydro-8,11a-beta-dimethyl-3-methylene-1-alpha,2-beta,11-beta-trihydrox y- 981-15-7
2H-1,11c-beta-(Epoxymethano)-phenanthro(10,1-bc)pyran-5,10(3H,6a-beta-H)-d ione, 1,3a-beta,4,7,7a-alpha,11,11a,11b-octahydro-1-alpha,2-alpha,4-beta,11-beta-tetrahydr oxy-3-alpha,18,11a-beta-trimethyl-, 4-acetate 84062-60-2
5H-3,11c-beta-(Epoxymethano)phenanthro(10,1-bc)pyran-5-one, 1,2,3,3a,4,6a-beta,7,7a-alpha,10,11,11a,11b-alpha-dodecahydro-1-beta,2-alpha,3a-beta,4-beta,10-alpha,11- beta-hexahydroxy-3-alpha,8,11a-beta-trimethyl-, (+)- 21586-90-3
Disulfide, p-chlorophenyl trichloromethyl, reactionproduct with triethyl phosphite 21586-90-3
2,6-Epoxy-2H-naphthaceno(1,2-b)oxocin-14-carboxylicacid, 3,4,5,6,9,11,12,13,14,16-decahydro-11-((6-deoxy-3-C-methyl-2,3,4-tri-O-methyl-alpha-L-mannopyranosy l)oxy)-4-(dimethylamino)-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-, (2-alpha,3-beta,4-alpha,5-beta,6-alpha,11-beta,13-alpha,14-alpha)-(+)- 64267-45-4
2,6-Epoxy-2H-naphthaceno(1,2-b)oxocin-14-carboxylicacid, 3,4,5,6,9,11,12,13,14,16-decahydro-4-(dimethylamino)-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-di oxo-, methyl ester 62422-00-8
2,6-Epoxy-2H-naphthaceno(1,2-b)oxocin-14-carboxylicacid, 11-((6-deoxy-3-C-methyl-2,3,4-tri-O-methyl-alpha-L-mannopyranosyl)oxy)-4-(dimethylamino)-3,4,5,6,9,11,12,13, 14,16-decahydro-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-,methyl ester,N-oxide, (2-alpha,3-beta,4-alpha,5-beta,6-alpha,11-beta,13-alpha,14-alpha)-(+)- 64457-65-4
2,6-Epoxy-2H-naphthaceno(1,2-b)oxocin-14-carboxylicacid, 11-((2,6-dideoxy-4-O-(2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)-3-O-methyl-alpha-L-lyxo-hexopyranosyl)oxy)-5-( (O-2,6-dideoxy-3-O-methyl-alpha-L-lyxo-hexopyranosyl-(1-4)-O-2,3,6-trideoxy-3-C-methyl-3-nitr o-beta-L-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-4-(dimethy lamino)-3,4,5,6,9,11,12,13,14,16-decahydro-3,8,10,13-tetrahydroxy-6,13-dimethyl-9, 16-dioxo-, methyl ester,(2R-(2-alpha,3-beta,4-alpha,5-alpha,6-alpha,11-beta,13-alpha,14-alpha))- 91887-45-5
2,6-Epoxy-2H-naphthaceno(1,2-b)oxocin-14-carboxylicacid, 11-((2,6-dideoxy-3-O-methyl-alpha-L-lyxo-hexopyranosyl)oxy)-5-((O-2,6-dideoxy-3-O-methyl-alpha-L-lyxo-hexopy ranosyl-(1-4)-O-2,3,6-trideoxy-3-C-methyl-3-nitro-beta-L-ribo-hexopyranosyl-(1-4)-2,6-dide oxy-alpha-L-lyxo-hexopyranosyl)oxy)-4-(dimethylamino)-3,4,5,6,9,11,12,13,14,16-decahydro-3, 8,10,13-tetrahydroxy-6,13-dimethyl-9,16-dioxo-, methyl ester,(2R-(2-alpha,3-beta,4-alpha,5-alpha,6-alpha,11-beta,13-alpha,14-alpha))- 98805-73-3
2,6-Epoxy-2H-naphthaceno(1,2-b)oxocin-14-carboxylicacid, 11-((2,6-dideoxy-3-O-methyl-alpha-L-lyxo-hexopyranosyl)oxy)-5-((2,6-dideoxy-4-O-(2,3,6-trideoxy-3-C-methyl-3 -nitro-beta-L-ribo-hexopyranosyl)-alpha-L-lyxo-hexopyranosyl)oxy)-4-(dimethylamino)-3,4,5,6,9 ,11,12,13,14,16-decahydro-3,8,10,13-tetrahydroxy-6,13-dimethyl-9,16-dioxo-, methyl ester, (2R-(2-alpha,3-beta,4-alpha,5-alpha,6-alpha,11-beta,13-alpha,14-alpha))- 91887-42-2
2,6-Epoxy-2H-naphthaceno(1,2-b)oxocin-14-carboxylicacid,5-((2,6-dideoxy-4-O-(2,3,6-trideoxy-3-C-methyl-3-nitro-beta-L-ribo-hexopyranosyl)-alpha-L-lyxo-hexopyranosyl)oxy)-4-(dimethylamino)-3,4,5,6,9,11,12,13,14,16-decahydro-3,8,10,11,13-pentahydroxy-6,13-d imethyl-9,16-dioxo-, methylester(2R-(2-alpha,3-beta,4-alpha,5-alpha,6-alpha,11-beta,13-alpha,14-alpha))- 91887-41-1
2,6-Epoxy-2H-naphthaceno(1,2-b)oxocin-14-carboxylicacid, 4-(dimethylamino)-3,4,5,6,9,11,12,13,14,16-decahydro-6,13-dimethyl-9,16-dioxo-8-methoxy-3,5,10,11,13-pentahy droxy-, methyl ester,(2-alpha,3-beta,4-alpha,5-beta,6-alpha,11-beta,13-alpha,14-alpha)- 62421-98-1
2,6-Epoxy-2H-naphthaceno(1,2-b)oxocin-14-carboxylicacid, 4-(dimethylamino)-3,4,5,6,9,11,12,13,14,16-decahydro-3,5,8,10,11,13-hexahydroxy-6,13-dimethyl-9,16-dioxo-, methyl ester, (2-alpha,3-beta,4-alpha,5-beta,6-alpha,11-beta,13-alpha,14-alpha)- 11052-70-3
2,6-Epoxy-2H-naphthaceno(1,2-b)oxocin-14-carboxylicacid, 4-(dimethylamino)-3,4,5,6,9,16-hexahydro-3,5,8,10-tetrahydroxy-6,13-dimethyl-9,16-dioxo-, methyl ester, (2-alpha,3-beta,4-alpha,5-beta,6-alpha)- 11052-69-0
Disulfide, dibenzyl 150-60-7
2,6-Epoxy-2H-naphthaceno(1,2-b)oxocin-9,16-dione,4-(dimethylamino)-3,4,5,6,11,12,13,14-octahydro-3,5,8,10,13-pentahydroxy-11-methoxy-6,13-dimethyl-, (2-alpha,3-beta,4-alpha,5-beta,6-alpha,11-alpha,13-alpha)-(+)- 71628-96-1

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net